相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
Aristeidis Chaidos et al.
BLOOD (2013)
Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma
Jing-li Gu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
Yawara Kawano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients
N. Hosen et al.
LEUKEMIA (2012)
Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors
A. Ikegame et al.
LEUKEMIA (2012)
Tumor-initiating capacity of CD138- and CD138+ tumor cells in the 5T33 multiple myeloma model
E. Van Valckenborgh et al.
LEUKEMIA (2012)
Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
Jana Jakubikova et al.
BLOOD (2011)
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Julie Mathieu et al.
CANCER RESEARCH (2011)
Retinoids Regulate Stem Cell Differentiation
Lorraine J. Gudas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
Anurag Purushothaman et al.
BLOOD (2010)
Sdc1 negatively modulates carcinoma cell motility and invasion
Tohru Ishikawa et al.
EXPERIMENTAL CELL RESEARCH (2010)
Bone marrow stromal cell interaction reduces Syndecan-1 expression and induces kinomic changes in myeloma cells
Gwenny M. Fuhler et al.
EXPERIMENTAL CELL RESEARCH (2010)
Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells
Sally K. Martin et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma
S. Reid et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2010)
Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms
Sarah K. Brennan et al.
PLOS ONE (2010)
Embryonic stem cell markers expression in cancers
Matthieu Schoenhals et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
Hiroshi Ikeda et al.
CLINICAL CANCER RESEARCH (2009)
All-trans retinoic acid can intensify the growth inhibition and differentiation induction effect of rosiglitazone on multiple myeloma cells
Haiwen Huang et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6
Nili Dezorella et al.
EXPERIMENTAL CELL RESEARCH (2009)
Suppression of Oct4 by Germ Cell Nuclear Factor Restricts Pluripotency and Promotes Neural Stem Cell Development in the Early Neural Lineage
Wado Akamatsu et al.
JOURNAL OF NEUROSCIENCE (2009)
IRF4 addiction in multiple myeloma
Arthur L. Shaffer et al.
NATURE (2008)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar et al.
BLOOD (2008)
Characterization of in vitro growth of multiple myeloma cells
Mihaela Zlei et al.
EXPERIMENTAL HEMATOLOGY (2007)
Hypoxia-inducible factors, stem cells, and cancer
Brian Keith et al.
CELL (2007)
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
Radek Spisek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype
S Yaccoby
CLINICAL CANCER RESEARCH (2005)
Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation
PL Gu et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Hypoxia-induced dedifferentiation of tumor cells -: A mechanism behind heterogeneity and aggressiveness of solid tumors
H Axelson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Regulation of plasma-cell development
M Shapiro-Shelef et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Characterization of clonogenic multiple myeloma cells
W Matsui et al.
BLOOD (2004)
The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression
F Medina et al.
BLOOD (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
S Zhou et al.
NATURE MEDICINE (2001)
分享论文
